Alex Rolfe
28 works · 2,454 citations · h-index 13
Top works
- Characterization of single-nucleotide polymorphisms in coding regions of human genes
- Transcriptional regulatory code of a eukaryotic genome
- Genome-wide Map of Nucleosome Acetylation and Methylation in Yeast
- Control of Pancreas and Liver Gene Expression by HNF Transcription Factors
- Tissue-specific transcriptional regulation has diverged significantly between human and mouse
- High-resolution computational models of genome binding events
- Global Position and Recruitment of HATs and HDACs in the Yeast Genome
- Core transcriptional regulatory circuitry in human hepatocytes
- Genotype to Phenotype: A Complex Problem
- Control of Transcription by Cell Size
- Bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with human papillomavirus-associated malignancies
- Combination Therapy with NHS-muIL12 and Avelumab (anti-PD-L1) Enhances Antitumor Efficacy in Preclinical Cancer Models
- Quantitative Systems Pharmacology Approaches for Immuno‐Oncology: Adding Virtual Patients to the Development Paradigm
- Development and Evaluation of a Panel of Filovirus Sequence Capture Probes for Pathogen Detection by Next-Generation Sequencing
- Bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in advanced squamous cell carcinoma of the head and neck: results from a phase I cohort
- Rapid Resistome Fingerprinting and Clonal Lineage Profiling of Carbapenem-Resistant Klebsiella pneumoniae Isolates by Targeted Next-Generation Sequencing
- Next-Generation Sequencing for Typing and Detection of Resistance Genes: Performance of a New Commercial Method during an Outbreak of Extended-Spectrum-Beta-Lactamase-Producing Escherichia coli
- Identification of tumor‐associated macrophage subsets that are associated with breast cancer prognosis
- Observational Study of PD-L1, TGF-β, and Immune Cell Infiltrates in Hepatocellular Carcinoma
- Abstract CT075: Phase I evaluation of M7824, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with human papillomavirus (HPV)-associated malignancies